Black patients more likely to be excluded from pancreatic cancer clinical trials

$ 19.50

4.6
(292)
In stock
Description

Black Patients Less Likely to Get Into Pancreatic Cancer Clinical

Multiple Myeloma in the Black Community

Issue 13 - The Cancer Letter

Cancer disruptors: When Bernie Fisher refused to grovel - The Cancer Letter

Disparities in Clinical Research and Cancer Treatment

Mission Possible: Improving Diversity in Cancer Clinical Trials

The Targeted Pulse: New Pancreatic Cancer Therapy, Shifts in Lung

Issue 13 - The Cancer Letter

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus

Bassel El-Rayes named deputy director of O'Neal Comprehensive Cancer Center - The Cancer Letter

Twice as Many African Americans as Whites have Multiple Myeloma

Issue 13 - The Cancer Letter

Flowchart of the Norwegian pancreatic cancer trial-1